Saad F, Winquist E, Hubay S, Berry S, Assi H, Levesque E, Aucoin N, Czaykowski P, Lattouf J-B, Alloul K, Stewart J, Sridhar SS. Efficacy, quality of life, and safety of cabazitaxel in Canadian metastatic castration-resistant prostate cancer patients treated or not with prior abiraterone. CUAJ [Internet]. 2016 Apr. 18 [cited 2024 May 4];10(3-4):102-9. Available from: https://cuaj.ca/index.php/journal/article/view/3470